HomeInsightsPE

Saroja Pharma Industries India Ltd P/E Ratio

Saroja Pharma Industries India Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

1.6 K

stocks traded

Last Updated time: 22 Jul 9.00 AM

Image

Saroja Pharma Industries India Ltd

NSE: SarojaPharmaIn

PE

19.6

Last updated : 18 Jul 24

Key Highlights

    The P/E Ratio of Saroja Pharma Industries India Ltd is 19.6 as of 18 Jul 24 .a1#The P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2023 . This represents a CAGR of 0.0% over 3 years. a1#The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 42.7 as of 18 Jul 15:30 .a1#The PE Ratio of Trading Industry has changed from 24.9 to 44.0 in 5 years. This represents a CAGR of 12.06%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 23.8. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.4. The PE Ratio of Trading industry is 71.5. In 2024a1#The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 3 years. a1#The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2023 . This represents a CAGR of 0.0% over 3 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Saroja Pharma Industries India Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Saroja Pharma Industries India Ltd

Period
Mar '210
Mar '220
Mar '230
Image

Saroja Pharma Industries India Ltd

NSE: SarojaPharmaIn

PRICE

42.7

0.00 (0.00%)

stock direction

Last updated : 18 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Saroja Pharma Industries India Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

PE Ratio of Trading Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Saroja Pharma Industries India Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Saroja Pharma Industries India Ltd

Period
Mar '210
Mar '220
Mar '230

* All values are a in crore

×

Historical Dividend Payout of Saroja Pharma Industries India Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Saroja Pharma Industries India Ltd

Period
Mar '210
Mar '220
Mar '230

* All values are a in %

About Saroja Pharma Industries India Ltd

About Saroja Pharma Industries India Ltd

    Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.' During this time, they focused on building a strong foundation and laying the groundwork for their future growth and success. With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry. Gradually, as Company expanded and gained momentum, the Promoters made a significant decision to convert their business from a Private Limited to a Public Limited, through which the Company was establish. Thus, transformation opened up new avenues for growth, allowing it to access a wider pool of investors and enhance the overall market presence. With the new status as a Public Limited Company, Saroja Pharma Industries India Limited further strengthen position into pharmaceutical and healthcare sectors. Thereafter, the Promoters envisioned leveraging the Company's expanded resources, increased capital formation, and enhanced market reach. Under the leadership of Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, Company continues for excellence, innovation, and global integration. Their commitment in providing high-quality pharmaceutical and healthcare products has helped it earn recognition and trust from both domestic and international customers. With a customer-centric approach and a focus on industry-leading practices, Company is poised to make a significant impact in the global healthcare landscape. Since established, the Company provide service deliverance in chemical trading with the best premium pharmaceutical companies in India and abroad for cost effective human and veterinary medicine. Presently, the Company trade into Active Pharmaceuticals Ingredients (API), Pharma Intermediates, Specialty Chemicals, Intermediates for Pharma trading and Solvents used for pharmaceutical products in human and veterinary medicine. The product demand by their clientele is manufactured as per their specifications by suppliers initially in sample size thereafter on clients testing and approving the order is finalized. The approved specified product is manufactured for the order quantity to be dispatched by the appropriate mode of transport within India or abroad. Prior to this, the Company witnessed a substantial expansion in its clientele base over the past two years. This growth has propelled the Company to venture into the manufacturing of API Pharma products, in making cost-effective contributions to human and veterinary medicine. The Company is planning for a Public Issue of 10,84,800 Equity shares aggregating to Rs 9.11 Crores by raising capital through Fresh Issue.

Saroja Pharma Industries India Ltd News Hub

News

Saroja Pharma Industries India announces board meeting date

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Compan...

Read more

24 May 202418:53

News

Saroja Pharma Industries India to convene board meeting

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Compan...

Read more

07 Nov 202317:17

News

NSE SME Saroja Pharma Industries lists at discount

The scrip was listed at Rs 65, a discount of 22.62% compared with the issue price. The scr...

Read more

13 Sep 202311:00

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199